My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
BSE: 533212 | NSE: GKB | Medical Equipment/Supplies/Accessories | Small Cap
1. Is GKB Ophthalmics Ltd a good quality company?
Data is not available for this company.
2. Is GKB Ophthalmics Ltd undervalued or overvalued?
The key valuation ratios of GKB Ophthalmics Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is GKB Ophthalmics Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of GKB Ophthalmics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | 3.8% | 8.1% | -4.3% | -0.4% | -1.5% | -4.9% | -6.8% | -7.5% | -1.2% | -3.3% | - | ||
| Value Creation Index ⓘ | -0.7 | -0.4 | -1.3 | -1.0 | -1.1 | -1.4 | -1.5 | -1.5 | -1.1 | -1.2 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 32.2 | 31.4 | 29.9 | 31.2 | 38.3 | 36.9 | 30.5 | 25.6 | 21.3 | 27.1 | 30 | ||
| YoY Gr. Rt. % | - | -2.6% | -4.9% | 4.4% | 22.9% | -3.7% | -17.5% | -16.1% | -16.5% | 26.8% | - | ||
| Adj EPS ⓘ | -2 | 1.3 | -7 | -3 | -3.4 | -6.4 | -8.1 | -8.5 | -2.9 | -4.7 | -1.7 | ||
| YoY Gr. Rt. % | - | NA | -633.3% | NA | NA | NA | NA | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | 41.3 | 43.3 | 36.8 | 69.7 | 71.2 | 64.9 | 68.5 | 69.9 | 65 | 60.3 | 58.7 | ||
| Adj Net Profit ⓘ | -0.8 | 0.6 | -2.9 | -1.2 | -1.4 | -2.7 | -3.8 | -4.3 | -1.5 | -2.4 | -1 | ||
| Cash Flow from Ops. ⓘ | 2 | 5.5 | 5.9 | -11.9 | -4.2 | -3.7 | 5.3 | 6.1 | 2.1 | 2.3 | - | ||
| Debt/CF from Ops. ⓘ | 7.7 | 2.3 | 1.5 | -0.6 | -1.7 | -2.7 | 1.9 | 1.6 | 5.7 | 5 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -1.9% | -6.7% | -3.9% | 26.8% | ||||||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||||||
| BVPS ⓘ | 4.3 | -3.3 | -4.1 | -7.2 | ||||||||
| Share Price | 11.7% | -3.9% | 32.8% | 38.9% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | -4.6 | 3.1 | -17.6 | -5.6 | -4.9 | -9.4 | -12.2 | -12.3 | -4.3 | -7.4 | -2.9 | |
| Op. Profit Mgn % ⓘ | 7.4 | 18.5 | -2.6 | -7.8 | -1.1 | -2.7 | -3.3 | -2.9 | -1.3 | -1.5 | 3.2 | |
| Net Profit Mgn % ⓘ | -2.5 | 1.8 | -9.8 | -4 | -3.7 | -7.2 | -12.3 | -16.8 | -6.9 | -8.7 | -2.9 | |
| Debt to Equity ⓘ | 0.9 | 0.7 | 0.6 | 0.3 | 0.2 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0 | |
| Working Cap Days ⓘ | 347 | 356 | 353 | 297 | 236 | 275 | 328 | 355 | 383 | 287 | 327 | |
| Cash Conv. Cycle ⓘ | 235 | 225 | 197 | 160 | 148 | 182 | 190 | 128 | 144 | 90 | 56 | |
Sales growth is good in last 4 quarters at 19.86%
Return on Equity is Poor
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -1.7 | 8.5 |
| TTM Sales (₹ Cr.) | 29.8 | 73.4 |
| BVPS (₹.) ⓘ | 58.7 | 129.9 |
| Reserves (₹ Cr.) ⓘ | 25 | 60 |
| P/BV ⓘ | 1.77 | 0.80 |
| PE ⓘ | 0.00 | 12.31 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 63.30 / 145.00 |
| All Time Low / High (₹) | 12.25 / 209.20 |
| Market Cap (₹ Cr.) | 52.4 |
| Equity (₹ Cr.) | 5 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 59 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
